Mainz Biomed BV (MYNZ)

$6.00 -$0.55 (-8.27%) 4:37 PM 12/10/24
NASDAQ | $USD | Diagnostics & Research

Stock Data

  • Market Cap

    $13.96M
  • Day's Range

    $5.90 - $6.94
  • Volume

    2,784,651
  • 52 Week Low / High

    $0.18 - $7.95
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

MYNZ's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
0
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
$9.67
Target Price

Company News

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

  • The Covid Era Tech Promises To Reinvent Cancer Treatment — Oct 1st, 2024

    The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic t...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free